Efficiency of Different Serological Methods for Diagnosing Epstein−Barr Virus Infection and Atypical Serological Profiles
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70724 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Firdevs Güvenç und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Antibodies, Viral, Herpesvirus 4, Human, Serologic Tests. Die Arbeit nennt 23 Literaturangaben. Gefördert von: This study was supported by EUROIMMUN provided diagnostic kits free of charge..
Abstract (Originalsprache)
Diagnosis of Epstein–Barr virus (EBV) infection is primarily based on the detection of specific antibodies against EBV antigens associated with different stages of infection. This study compared enzyme‐linked immunosorbent assay (ELISA) and immunoblot (IB) with the reference method, immunofluorescence assay (IFA), to evaluate their performance in defining EBV infection stages and atypical antibody profiles. Sera from symptomatic and asymptomatic pediatric patients were analyzed for EBV VCA (viral capsid antigen) IgM/IgG, EA (early antigen), and EBNA (Epstein–Barr nuclear antigen) IgG to determine EBV infection stages. Avidity ELISA for VCA IgG was performed to assess its utility for disease staging and in clarifying atypical antibody profiles. EBV DNA analysis was performed to investigate its complementary role alongside EBV serology. Almost perfect agreement was observed between ELISA and IFA (κ = 0.81) and between IB and IFA (κ = 0.82) for EBV staging, which further increased with the addition of VCA IgG avidity ELISA (κ = 0.97). During early primary EBV infection, PCR showed a sensitivity of 60% and may support diagnosis when combined with serological staging. In conclusion, the high concordance between IFA and ELISA including avidity suggests its suitability for routine diagnostics, particularly when IFA is impractical due to its technical complexity and cost.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Medical Microbiology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.
- EUROIMMUN Turkey, Istanbul, Turkey.
- Institute for Experimental Immunology, affiliated with EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany.
- Division of Pediatric infection, Department of Child Health and Diseases, Ankara Yildirim Beyazit University, Ankara Bilkent City Hospital, Ankara, Turkey.
ORCID-Profile: Firdevs Güvenç, Alparslan Toyran, Sibel Aydoğan, Ayten Öz Kamiloğlu, Evelin Grage Griebenow, Aslınur Özkaya Parlakay, Bedia Dinç
Förderung
- This study was supported by EUROIMMUN provided diagnostic kits free of charge.
Zitieren
APA
Güvenç, F., Toyran, A., Aydoğan, S., Kamiloğlu, A. Ö., Grage Griebenow, E., Parlakay, A. Ö., & Dinç, B. (2025). Efficiency of Different Serological Methods for Diagnosing Epstein−Barr Virus Infection and Atypical Serological Profiles. Journal of Medical Virology. https://doi.org/10.1002/jmv.70724
Vancouver
Güvenç F, Toyran A, Aydoğan S, Kamiloğlu AÖ, Grage Griebenow E, Parlakay AÖ, et al. Efficiency of Different Serological Methods for Diagnosing Epstein−Barr Virus Infection and Atypical Serological Profiles. Journal of Medical Virology. 2025. doi:10.1002/jmv.70724
BibTeX
@article{Gven2025,
author = {Güvenç, Firdevs and Toyran, Alparslan and Aydoğan, Sibel and Kamiloğlu, Ayten Öz and Grage Griebenow, Evelin and Parlakay, Aslınur Özkaya and Dinç, Bedia},
title = {Efficiency of Different Serological Methods for Diagnosing Epstein−Barr Virus Infection and Atypical Serological Profiles},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70724}
}
EUVIMED